LEADER 03704nam 2200769Ia 450 001 9910963453703321 005 20200520144314.0 010 $a9786612777158 010 $a9781444347784 010 $a1444347780 010 $a9781282777156 010 $a1282777157 010 $a9781444324792 010 $a1444324799 035 $a(CKB)2670000000047496 035 $a(EBL)589186 035 $a(OCoLC)671495160 035 $a(SSID)ssj0000423051 035 $a(PQKBManifestationID)12189880 035 $a(PQKBTitleCode)TC0000423051 035 $a(PQKBWorkID)10438910 035 $a(PQKB)11673591 035 $a(MiAaPQ)EBC589186 035 $a(Au-PeEL)EBL589186 035 $a(CaPaEBR)ebr10419247 035 $a(CaONFJC)MIL277715 035 $a(Perlego)1011266 035 $a(EXLCZ)992670000000047496 100 $a20100325d2010 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aMetabolic risk for cardiovascular disease /$fedited by Robert H. Eckel 205 $a1st ed. 210 $aDallas, TX $cAmerican Heart Association ;$aChichester, West Sussex, UK $cWiley-Blackwell$d2010 215 $a1 online resource (261 p.) 225 1 $aAHA clinical series 300 $aDescription based upon print version of record. 311 08$a9781405181044 311 08$a1405181044 320 $aIncludes bibliographical references and index. 327 $aMetabolic Riskfor CardiovascularDisease; Contents; Contributors; Foreword; 1 Insulin action and beta-cell function: role in metabolic regulation; 2 Lipid and lipoprotein metabolism, and risk for cardiovascular disease; 3 Tobacco and risk for cardiovascular disease; 4 Nutrition and risk for cardiovascular disease; 5 Physical activity and cardiovascular health; 6 The obesity epidemic and cardiovascular risk; 7 Insulin resistance, the metabolic syndrome, and cardiovascular risk; 8 Diabetes mellitus and cardiovascular risk; 9 Lipid management and cardiovascular risk reduction 327 $a10 Obesity management and cardiovascular risk reduction11 Diabetes management and cardiovascular risk reduction; 12 A healthy lifestyle and cardiovascular risk reduction; Index; Author Disclosure Table 330 $aThe relationship of metabolic diseases to cardiovascular disease (CVD) is reaching epidemic proportions. This relates mostly to the increasing prevalence of obesity, the metabolic syndrome and type 2 diabetes. This book outlines and addresses the metabolic factors and related diseases that contribute to CVD, including brief introductions to metabolic pathways including lipid and lipoprotein metabolism, macronutrient fuel partitioning, insulin action and body weight regulation. Mechanisms that relate to becoming obese, maintenance of the obese state, the dyslipidemias, and glucose intolerance 410 0$aAHA clinical series. 606 $aCardiovascular system$xDiseases$xRisk factors 606 $aMetabolic syndrome 606 $aObesity$xComplications 606 $aLipids$xMetabolism$xDisorders$xComplications 606 $aDiabetes$xComplications 615 0$aCardiovascular system$xDiseases$xRisk factors. 615 0$aMetabolic syndrome. 615 0$aObesity$xComplications. 615 0$aLipids$xMetabolism$xDisorders$xComplications. 615 0$aDiabetes$xComplications. 676 $a616.1/071 701 $aEckel$b Robert H$01806116 712 02$aAmerican Heart Association. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910963453703321 996 $aMetabolic risk for cardiovascular disease$94355098 997 $aUNINA